Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study Comparing Outcome of Patients Aged From 50 to 70 Years With or Without Donor
Inclusion Criteria:
- 50 to 70 years
- For myelodysplasia other than CMML: patients can be included if they have at least
one of these criteria:
1. IPSSintermediate 1 and poor cytogenetics (complex, 3 or 7 abnormality);
2. thrombopenia < 20x10ex9/L:
3. IPSS intermediate 2 or high
- For CMML: patients can be included if they have at least one of these criteria:
1. 2 of these criteria: hyperleucocytosis > 10x10exp9/L, splenomegaly>18cm,
hemoglobin < 10gr/dl, platelet < 100x10ex9/L
2. IPSS intermediate 2 or high
Exclusion Criteria:
- Patient not eligible for transplantation (including patients without donor)because of
severe co-morbidity including:
- Renal failure with creatinine clearance < 30ml/min
- Cirrhosis or hepatic failure
- Respiratory disease with vital capacity < 30%
- Uncontrolled cardiac failure
- Uncontrolled neurological disease
- Poor performance status with karnofsky < or = 60%